1 Market Overview

1.1 Product Overview and Scope of Cancer Genome Analysis

1.2 Classification of Cancer Genome Analysis by Type

1.2.1 Overview: Global Cancer Genome Analysis Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cancer Genome Analysis Revenue Market Share by Type in 2020

1.2.3 Solid Tissue Analysis

1.2.4 Liquid Tissue Analysis

1.3 Global Cancer Genome Analysis Market by Application

1.3.1 Overview: Global Cancer Genome Analysis Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Clinical

1.3.3 Pharmaceutical

1.3.4 Research

1.4 Global Cancer Genome Analysis Market Size & Forecast

1.5 Global Cancer Genome Analysis Market Size and Forecast by Region

1.5.1 Global Cancer Genome Analysis Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cancer Genome Analysis Market Size by Region, (2016-2021)

1.5.3 North America Cancer Genome Analysis Market Size and Prospect (2016-2026)

1.5.4 Europe Cancer Genome Analysis Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cancer Genome Analysis Market Size and Prospect (2016-2026)

1.5.6 South America Cancer Genome Analysis Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cancer Genome Analysis Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cancer Genome Analysis Market Drivers

1.6.2 Cancer Genome Analysis Market Restraints

1.6.3 Cancer Genome Analysis Trends Analysis

2 Company Profiles

2.1 Abbott Diagnostics

2.1.1 Abbott Diagnostics Details

2.1.2 Abbott Diagnostics Major Business

2.1.3 Abbott Diagnostics Cancer Genome Analysis Product and Solutions

2.1.4 Abbott Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Diagnostics Recent Developments and Future Plans

2.2 AccuraGen Inc

2.2.1 AccuraGen Inc Details

2.2.2 AccuraGen Inc Major Business

2.2.3 AccuraGen Inc Cancer Genome Analysis Product and Solutions

2.2.4 AccuraGen Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 AccuraGen Inc Recent Developments and Future Plans

2.3 Acuamark Diagnostics

2.3.1 Acuamark Diagnostics Details

2.3.2 Acuamark Diagnostics Major Business

2.3.3 Acuamark Diagnostics Cancer Genome Analysis Product and Solutions

2.3.4 Acuamark Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Acuamark Diagnostics Recent Developments and Future Plans

2.4 Admera Health, LLC

2.4.1 Admera Health, LLC Details

2.4.2 Admera Health, LLC Major Business

2.4.3 Admera Health, LLC Cancer Genome Analysis Product and Solutions

2.4.4 Admera Health, LLC Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Admera Health, LLC Recent Developments and Future Plans

2.5 Agena Bioscience, Inc

2.5.1 Agena Bioscience, Inc Details

2.5.2 Agena Bioscience, Inc Major Business

2.5.3 Agena Bioscience, Inc Cancer Genome Analysis Product and Solutions

2.5.4 Agena Bioscience, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Agena Bioscience, Inc Recent Developments and Future Plans

2.6 Agilent

2.6.1 Agilent Details

2.6.2 Agilent Major Business

2.6.3 Agilent Cancer Genome Analysis Product and Solutions

2.6.4 Agilent Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Agilent Recent Developments and Future Plans

2.7 Almac Diagnostics

2.7.1 Almac Diagnostics Details

2.7.2 Almac Diagnostics Major Business

2.7.3 Almac Diagnostics Cancer Genome Analysis Product and Solutions

2.7.4 Almac Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Almac Diagnostics Recent Developments and Future Plans

2.8 Amoy Diagnostics Co., Ltd.

2.8.1 Amoy Diagnostics Co., Ltd. Details

2.8.2 Amoy Diagnostics Co., Ltd. Major Business

2.8.3 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product and Solutions

2.8.4 Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Amoy Diagnostics Co., Ltd. Recent Developments and Future Plans

2.9 Anchor Dx

2.9.1 Anchor Dx Details

2.9.2 Anchor Dx Major Business

2.9.3 Anchor Dx Cancer Genome Analysis Product and Solutions

2.9.4 Anchor Dx Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Anchor Dx Recent Developments and Future Plans

2.10 ANGLE plc

2.10.1 ANGLE plc Details

2.10.2 ANGLE plc Major Business

2.10.3 ANGLE plc Cancer Genome Analysis Product and Solutions

2.10.4 ANGLE plc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 ANGLE plc Recent Developments and Future Plans

2.11 ApoCell, Inc.

2.11.1 ApoCell, Inc. Details

2.11.2 ApoCell, Inc. Major Business

2.11.3 ApoCell, Inc. Cancer Genome Analysis Product and Solutions

2.11.4 ApoCell, Inc. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 ApoCell, Inc. Recent Developments and Future Plans

2.12 ArcherDx, Inc

2.12.1 ArcherDx, Inc Details

2.12.2 ArcherDx, Inc Major Business

2.12.3 ArcherDx, Inc Cancer Genome Analysis Product and Solutions

2.12.4 ArcherDx, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 ArcherDx, Inc Recent Developments and Future Plans

2.13 Asuragen

2.13.1 Asuragen Details

2.13.2 Asuragen Major Business

2.13.3 Asuragen Cancer Genome Analysis Product and Solutions

2.13.4 Asuragen Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Asuragen Recent Developments and Future Plans

2.14 AVIVA Biosciences

2.14.1 AVIVA Biosciences Details

2.14.2 AVIVA Biosciences Major Business

2.14.3 AVIVA Biosciences Cancer Genome Analysis Product and Solutions

2.14.4 AVIVA Biosciences Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 AVIVA Biosciences Recent Developments and Future Plans

2.15 Baylor Miraca Genetics Laboratories

2.15.1 Baylor Miraca Genetics Laboratories Details

2.15.2 Baylor Miraca Genetics Laboratories Major Business

2.15.3 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product and Solutions

2.15.4 Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Baylor Miraca Genetics Laboratories Recent Developments and Future Plans

2.16 Beckman Coulter, Inc.

2.16.1 Beckman Coulter, Inc. Details

2.16.2 Beckman Coulter, Inc. Major Business

2.16.3 Beckman Coulter, Inc. Cancer Genome Analysis Product and Solutions

2.16.4 Beckman Coulter, Inc. Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Beckman Coulter, Inc. Recent Developments and Future Plans

2.17 Becton, Dickinson and Company

2.17.1 Becton, Dickinson and Company Details

2.17.2 Becton, Dickinson and Company Major Business

2.17.3 Becton, Dickinson and Company Cancer Genome Analysis Product and Solutions

2.17.4 Becton, Dickinson and Company Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Becton, Dickinson and Company Recent Developments and Future Plans

2.18 BGI Genomics Co. Ltd

2.18.1 BGI Genomics Co. Ltd Details

2.18.2 BGI Genomics Co. Ltd Major Business

2.18.3 BGI Genomics Co. Ltd Cancer Genome Analysis Product and Solutions

2.18.4 BGI Genomics Co. Ltd Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 BGI Genomics Co. Ltd Recent Developments and Future Plans

2.19 Bioarray Genetics

2.19.1 Bioarray Genetics Details

2.19.2 Bioarray Genetics Major Business

2.19.3 Bioarray Genetics Cancer Genome Analysis Product and Solutions

2.19.4 Bioarray Genetics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Bioarray Genetics Recent Developments and Future Plans

2.20 Biocartis

2.20.1 Biocartis Details

2.20.2 Biocartis Major Business

2.20.3 Biocartis Cancer Genome Analysis Product and Solutions

2.20.4 Biocartis Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Biocartis Recent Developments and Future Plans

2.21 Biocept, Inc

2.21.1 Biocept, Inc Details

2.21.2 Biocept, Inc Major Business

2.21.3 Biocept, Inc Cancer Genome Analysis Product and Solutions

2.21.4 Biocept, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Biocept, Inc Recent Developments and Future Plans

2.22 Biodesix Inc

2.22.1 Biodesix Inc Details

2.22.2 Biodesix Inc Major Business

2.22.3 Biodesix Inc Cancer Genome Analysis Product and Solutions

2.22.4 Biodesix Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Biodesix Inc Recent Developments and Future Plans

2.23 BioFluidica

2.23.1 BioFluidica Details

2.23.2 BioFluidica Major Business

2.23.3 BioFluidica Cancer Genome Analysis Product and Solutions

2.23.4 BioFluidica Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 BioFluidica Recent Developments and Future Plans

2.24 bioMérieux Diagnostics

2.24.1 bioMérieux Diagnostics Details

2.24.2 bioMérieux Diagnostics Major Business

2.24.3 bioMérieux Diagnostics Cancer Genome Analysis Product and Solutions

2.24.4 bioMérieux Diagnostics Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 bioMérieux Diagnostics Recent Developments and Future Plans

2.25 Bioneer Corporation

2.25.1 Bioneer Corporation Details

2.25.2 Bioneer Corporation Major Business

2.25.3 Bioneer Corporation Cancer Genome Analysis Product and Solutions

2.25.4 Bioneer Corporation Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Bioneer Corporation Recent Developments and Future Plans

2.26 Bio-Rad Laboratories, Inc

2.26.1 Bio-Rad Laboratories, Inc Details

2.26.2 Bio-Rad Laboratories, Inc Major Business

2.26.3 Bio-Rad Laboratories, Inc Cancer Genome Analysis Product and Solutions

2.26.4 Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 Bio-Rad Laboratories, Inc Recent Developments and Future Plans

2.27 Bio-Techne

2.27.1 Bio-Techne Details

2.27.2 Bio-Techne Major Business

2.27.3 Bio-Techne Cancer Genome Analysis Product and Solutions

2.27.4 Bio-Techne Cancer Genome Analysis Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Bio-Techne Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cancer Genome Analysis Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cancer Genome Analysis Players Market Share

3.2.2 Top 10 Cancer Genome Analysis Players Market Share

3.2.3 Market Competition Trend

3.3 Cancer Genome Analysis Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cancer Genome Analysis Revenue and Market Share by Type (2016-2021)

4.2 Global Cancer Genome Analysis Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cancer Genome Analysis Revenue Market Share by Application (2016-2021)

5.2 Cancer Genome Analysis Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cancer Genome Analysis Revenue by Type (2016-2026)

6.2 North America Cancer Genome Analysis Revenue by Application (2016-2026)

6.3 North America Cancer Genome Analysis Market Size by Country

6.3.1 North America Cancer Genome Analysis Revenue by Country (2016-2026)

6.3.2 United States Cancer Genome Analysis Market Size and Forecast (2016-2026)

6.3.3 Canada Cancer Genome Analysis Market Size and Forecast (2016-2026)

6.3.4 Mexico Cancer Genome Analysis Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cancer Genome Analysis Revenue by Type (2016-2026)

7.2 Europe Cancer Genome Analysis Revenue by Application (2016-2026)

7.3 Europe Cancer Genome Analysis Market Size by Country

7.3.1 Europe Cancer Genome Analysis Revenue by Country (2016-2026)

7.3.2 Germany Cancer Genome Analysis Market Size and Forecast (2016-2026)

7.3.3 France Cancer Genome Analysis Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cancer Genome Analysis Market Size and Forecast (2016-2026)

7.3.5 Russia Cancer Genome Analysis Market Size and Forecast (2016-2026)

7.3.6 Italy Cancer Genome Analysis Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cancer Genome Analysis Revenue by Type (2016-2026)

8.2 Asia-Pacific Cancer Genome Analysis Revenue by Application (2016-2026)

8.3 Asia-Pacific Cancer Genome Analysis Market Size by Region

8.3.1 Asia-Pacific Cancer Genome Analysis Revenue by Region (2016-2026)

8.3.2 China Cancer Genome Analysis Market Size and Forecast (2016-2026)

8.3.3 Japan Cancer Genome Analysis Market Size and Forecast (2016-2026)

8.3.4 South Korea Cancer Genome Analysis Market Size and Forecast (2016-2026)

8.3.5 India Cancer Genome Analysis Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cancer Genome Analysis Market Size and Forecast (2016-2026)

8.3.7 Australia Cancer Genome Analysis Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cancer Genome Analysis Revenue by Type (2016-2026)

9.2 South America Cancer Genome Analysis Revenue by Application (2016-2026)

9.3 South America Cancer Genome Analysis Market Size by Country

9.3.1 South America Cancer Genome Analysis Revenue by Country (2016-2026)

9.3.2 Brazil Cancer Genome Analysis Market Size and Forecast (2016-2026)

9.3.3 Argentina Cancer Genome Analysis Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cancer Genome Analysis Revenue by Type (2016-2026)

10.2 Middle East & Africa Cancer Genome Analysis Revenue by Application (2016-2026)

10.3 Middle East & Africa Cancer Genome Analysis Market Size by Country

10.3.1 Middle East & Africa Cancer Genome Analysis Revenue by Country (2016-2026)

10.3.2 Turkey Cancer Genome Analysis Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cancer Genome Analysis Market Size and Forecast (2016-2026)

10.3.4 UAE Cancer Genome Analysis Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cancer Genome Analysis Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cancer Genome Analysis Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cancer Genome Analysis Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cancer Genome Analysis Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cancer Genome Analysis Revenue Market Share by Region (2021-2026)

Table 6. Abbott Diagnostics Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Diagnostics Major Business

Table 8. Abbott Diagnostics Cancer Genome Analysis Product and Solutions

Table 9. Abbott Diagnostics Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. AccuraGen Inc Corporate Information, Head Office, and Major Competitors

Table 11. AccuraGen Inc Major Business

Table 12. AccuraGen Inc Cancer Genome Analysis Product and Solutions

Table 13. AccuraGen Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Acuamark Diagnostics Corporate Information, Head Office, and Major Competitors

Table 15. Acuamark Diagnostics Major Business

Table 16. Acuamark Diagnostics Cancer Genome Analysis Product and Solutions

Table 17. Acuamark Diagnostics Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Admera Health, LLC Corporate Information, Head Office, and Major Competitors

Table 19. Admera Health, LLC Major Business

Table 20. Admera Health, LLC Cancer Genome Analysis Product and Solutions

Table 21. Admera Health, LLC Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Agena Bioscience, Inc Corporate Information, Head Office, and Major Competitors

Table 23. Agena Bioscience, Inc Major Business

Table 24. Agena Bioscience, Inc Cancer Genome Analysis Product and Solutions

Table 25. Agena Bioscience, Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Agilent Corporate Information, Head Office, and Major Competitors

Table 27. Agilent Major Business

Table 28. Agilent Cancer Genome Analysis Product and Solutions

Table 29. Agilent Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Almac Diagnostics Corporate Information, Head Office, and Major Competitors

Table 31. Almac Diagnostics Major Business

Table 32. Almac Diagnostics Cancer Genome Analysis Product and Solutions

Table 33. Almac Diagnostics Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Amoy Diagnostics Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 35. Amoy Diagnostics Co., Ltd. Major Business

Table 36. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Product and Solutions

Table 37. Amoy Diagnostics Co., Ltd. Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Anchor Dx Corporate Information, Head Office, and Major Competitors

Table 39. Anchor Dx Major Business

Table 40. Anchor Dx Cancer Genome Analysis Product and Solutions

Table 41. Anchor Dx Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. ANGLE plc Corporate Information, Head Office, and Major Competitors

Table 43. ANGLE plc Major Business

Table 44. ANGLE plc Cancer Genome Analysis Product and Solutions

Table 45. ANGLE plc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. ApoCell, Inc. Corporate Information, Head Office, and Major Competitors

Table 47. ApoCell, Inc. Major Business

Table 48. ApoCell, Inc. Cancer Genome Analysis Product and Solutions

Table 49. ApoCell, Inc. Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. ArcherDx, Inc Corporate Information, Head Office, and Major Competitors

Table 51. ArcherDx, Inc Major Business

Table 52. ArcherDx, Inc Cancer Genome Analysis Product and Solutions

Table 53. ArcherDx, Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Asuragen Corporate Information, Head Office, and Major Competitors

Table 55. Asuragen Major Business

Table 56. Asuragen Cancer Genome Analysis Product and Solutions

Table 57. Asuragen Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. AVIVA Biosciences Corporate Information, Head Office, and Major Competitors

Table 59. AVIVA Biosciences Major Business

Table 60. AVIVA Biosciences Cancer Genome Analysis Product and Solutions

Table 61. AVIVA Biosciences Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Baylor Miraca Genetics Laboratories Corporate Information, Head Office, and Major Competitors

Table 63. Baylor Miraca Genetics Laboratories Major Business

Table 64. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Product and Solutions

Table 65. Baylor Miraca Genetics Laboratories Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Beckman Coulter, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. Beckman Coulter, Inc. Major Business

Table 68. Beckman Coulter, Inc. Cancer Genome Analysis Product and Solutions

Table 69. Beckman Coulter, Inc. Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Becton, Dickinson and Company Corporate Information, Head Office, and Major Competitors

Table 71. Becton, Dickinson and Company Major Business

Table 72. Becton, Dickinson and Company Cancer Genome Analysis Product and Solutions

Table 73. Becton, Dickinson and Company Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. BGI Genomics Co. Ltd Corporate Information, Head Office, and Major Competitors

Table 75. BGI Genomics Co. Ltd Major Business

Table 76. BGI Genomics Co. Ltd Cancer Genome Analysis Product and Solutions

Table 77. BGI Genomics Co. Ltd Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Bioarray Genetics Corporate Information, Head Office, and Major Competitors

Table 79. Bioarray Genetics Major Business

Table 80. Bioarray Genetics Cancer Genome Analysis Product and Solutions

Table 81. Bioarray Genetics Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Biocartis Corporate Information, Head Office, and Major Competitors

Table 83. Biocartis Major Business

Table 84. Biocartis Cancer Genome Analysis Product and Solutions

Table 85. Biocartis Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Biocept, Inc Corporate Information, Head Office, and Major Competitors

Table 87. Biocept, Inc Major Business

Table 88. Biocept, Inc Cancer Genome Analysis Product and Solutions

Table 89. Biocept, Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Biodesix Inc Corporate Information, Head Office, and Major Competitors

Table 91. Biodesix Inc Major Business

Table 92. Biodesix Inc Cancer Genome Analysis Product and Solutions

Table 93. Biodesix Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. BioFluidica Corporate Information, Head Office, and Major Competitors

Table 95. BioFluidica Major Business

Table 96. BioFluidica Cancer Genome Analysis Product and Solutions

Table 97. BioFluidica Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. bioMérieux Diagnostics Corporate Information, Head Office, and Major Competitors

Table 99. bioMérieux Diagnostics Major Business

Table 100. bioMérieux Diagnostics Cancer Genome Analysis Product and Solutions

Table 101. bioMérieux Diagnostics Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Bioneer Corporation Corporate Information, Head Office, and Major Competitors

Table 103. Bioneer Corporation Major Business

Table 104. Bioneer Corporation Cancer Genome Analysis Product and Solutions

Table 105. Bioneer Corporation Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. Bio-Rad Laboratories, Inc Corporate Information, Head Office, and Major Competitors

Table 107. Bio-Rad Laboratories, Inc Major Business

Table 108. Bio-Rad Laboratories, Inc Cancer Genome Analysis Product and Solutions

Table 109. Bio-Rad Laboratories, Inc Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Bio-Techne Corporate Information, Head Office, and Major Competitors

Table 111. Bio-Techne Major Business

Table 112. Bio-Techne Cancer Genome Analysis Product and Solutions

Table 113. Bio-Techne Cancer Genome Analysis Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Global Cancer Genome Analysis Revenue (USD Million) by Players (2019-2021)

Table 115. Global Cancer Genome Analysis Revenue Share by Players (2019-2021)

Table 116. Breakdown of Cancer Genome Analysis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 117. Cancer Genome Analysis Players Head Office, Products and Services Provided

Table 118. Cancer Genome Analysis Mergers & Acquisitions in the Past Five Years

Table 119. Cancer Genome Analysis New Entrants and Expansion Plans

Table 120. Global Cancer Genome Analysis Revenue (USD Million) by Type (2016-2021)

Table 121. Global Cancer Genome Analysis Revenue Share by Type (2016-2021)

Table 122. Global Cancer Genome Analysis Revenue Forecast by Type (2021-2026)

Table 123. Global Cancer Genome Analysis Revenue by Application (2016-2021)

Table 124. Global Cancer Genome Analysis Revenue Forecast by Application (2021-2026)

Table 125. North America Cancer Genome Analysis Revenue by Type (2016-2021) & (USD Million)

Table 126. North America Cancer Genome Analysis Revenue by Type (2021-2026) & (USD Million)

Table 127. North America Cancer Genome Analysis Revenue by Application (2016-2021) & (USD Million)

Table 128. North America Cancer Genome Analysis Revenue by Application (2021-2026) & (USD Million)

Table 129. North America Cancer Genome Analysis Revenue by Country (2016-2021) & (USD Million)

Table 130. North America Cancer Genome Analysis Revenue by Country (2021-2026) & (USD Million)

Table 131. Europe Cancer Genome Analysis Revenue by Type (2016-2021) & (USD Million)

Table 132. Europe Cancer Genome Analysis Revenue by Type (2021-2026) & (USD Million)

Table 133. Europe Cancer Genome Analysis Revenue by Application (2016-2021) & (USD Million)

Table 134. Europe Cancer Genome Analysis Revenue by Application (2021-2026) & (USD Million)

Table 135. Europe Cancer Genome Analysis Revenue by Country (2016-2021) & (USD Million)

Table 136. Europe Cancer Genome Analysis Revenue by Country (2021-2026) & (USD Million)

Table 137. Asia-Pacific Cancer Genome Analysis Revenue by Type (2016-2021) & (USD Million)

Table 138. Asia-Pacific Cancer Genome Analysis Revenue by Type (2021-2026) & (USD Million)

Table 139. Asia-Pacific Cancer Genome Analysis Revenue by Application (2016-2021) & (USD Million)

Table 140. Asia-Pacific Cancer Genome Analysis Revenue by Application (2021-2026) & (USD Million)

Table 141. Asia-Pacific Cancer Genome Analysis Revenue by Region (2016-2021) & (USD Million)

Table 142. Asia-Pacific Cancer Genome Analysis Revenue by Region (2021-2026) & (USD Million)

Table 143. South America Cancer Genome Analysis Revenue by Type (2016-2021) & (USD Million)

Table 144. South America Cancer Genome Analysis Revenue by Type (2021-2026) & (USD Million)

Table 145. South America Cancer Genome Analysis Revenue by Application (2016-2021) & (USD Million)

Table 146. South America Cancer Genome Analysis Revenue by Application (2021-2026) & (USD Million)

Table 147. South America Cancer Genome Analysis Revenue by Country (2016-2021) & (USD Million)

Table 148. South America Cancer Genome Analysis Revenue by Country (2021-2026) & (USD Million)

Table 149. Middle East & Africa Cancer Genome Analysis Revenue by Type (2016-2021) & (USD Million)

Table 150. Middle East & Africa Cancer Genome Analysis Revenue by Type (2021-2026) & (USD Million)

Table 151. Middle East & Africa Cancer Genome Analysis Revenue by Application (2016-2021) & (USD Million)

Table 152. Middle East & Africa Cancer Genome Analysis Revenue by Application (2021-2026) & (USD Million)

Table 153. Middle East & Africa Cancer Genome Analysis Revenue by Country (2016-2021) & (USD Million)

Table 154. Middle East & Africa Cancer Genome Analysis Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cancer Genome Analysis Picture

Figure 2. Global Cancer Genome Analysis Revenue Market Share by Type in 2020

Figure 3. Solid Tissue Analysis

Figure 4. Liquid Tissue Analysis

Figure 5. Cancer Genome Analysis Revenue Market Share by Application in 2020

Figure 6. Clinical Picture

Figure 7. Pharmaceutical Picture

Figure 8. Research Picture

Figure 9. Global Cancer Genome Analysis Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Cancer Genome Analysis Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Cancer Genome Analysis Revenue Market Share by Region (2016-2026)

Figure 12. Global Cancer Genome Analysis Revenue Market Share by Region in 2020

Figure 13. North America Cancer Genome Analysis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Cancer Genome Analysis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Cancer Genome Analysis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Cancer Genome Analysis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Cancer Genome Analysis Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Cancer Genome Analysis Market Drivers

Figure 19. Cancer Genome Analysis Market Restraints

Figure 20. Cancer Genome Analysis Market Trends

Figure 21. Abbott Diagnostics Recent Developments and Future Plans

Figure 22. AccuraGen Inc Recent Developments and Future Plans

Figure 23. Acuamark Diagnostics Recent Developments and Future Plans

Figure 24. Admera Health, LLC Recent Developments and Future Plans

Figure 25. Agena Bioscience, Inc Recent Developments and Future Plans

Figure 26. Agilent Recent Developments and Future Plans

Figure 27. Almac Diagnostics Recent Developments and Future Plans

Figure 28. Amoy Diagnostics Co., Ltd. Recent Developments and Future Plans

Figure 29. Anchor Dx Recent Developments and Future Plans

Figure 30. ANGLE plc Recent Developments and Future Plans

Figure 31. ApoCell, Inc. Recent Developments and Future Plans

Figure 32. ArcherDx, Inc Recent Developments and Future Plans

Figure 33. Asuragen Recent Developments and Future Plans

Figure 34. AVIVA Biosciences Recent Developments and Future Plans

Figure 35. Baylor Miraca Genetics Laboratories Recent Developments and Future Plans

Figure 36. Beckman Coulter, Inc. Recent Developments and Future Plans

Figure 37. Becton, Dickinson and Company Recent Developments and Future Plans

Figure 38. BGI Genomics Co. Ltd Recent Developments and Future Plans

Figure 39. Bioarray Genetics Recent Developments and Future Plans

Figure 40. Biocartis Recent Developments and Future Plans

Figure 41. Biocept, Inc Recent Developments and Future Plans

Figure 42. Biodesix Inc Recent Developments and Future Plans

Figure 43. BioFluidica Recent Developments and Future Plans

Figure 44. bioMérieux Diagnostics Recent Developments and Future Plans

Figure 45. Bioneer Corporation Recent Developments and Future Plans

Figure 46. Bio-Rad Laboratories, Inc Recent Developments and Future Plans

Figure 47. Bio-Techne Recent Developments and Future Plans

Figure 48. Global Cancer Genome Analysis Revenue Share by Players in 2020

Figure 49. Cancer Genome Analysis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 50. Global Top 3 Players Cancer Genome Analysis Revenue Market Share in 2020

Figure 51. Global Top 10 Players Cancer Genome Analysis Revenue Market Share in 2020

Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 53. Global Cancer Genome Analysis Revenue Share by Type in 2020

Figure 54. Global Cancer Genome Analysis Market Share Forecast by Type (2021-2026)

Figure 55. Global Cancer Genome Analysis Revenue Share by Application in 2020

Figure 56. Global Cancer Genome Analysis Market Share Forecast by Application (2021-2026)

Figure 57. North America Cancer Genome Analysis Sales Market Share by Type (2016-2026)

Figure 58. North America Cancer Genome Analysis Sales Market Share by Application (2016-2026)

Figure 59. North America Cancer Genome Analysis Revenue Market Share by Country (2016-2026)

Figure 60. United States Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Canada Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Mexico Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Europe Cancer Genome Analysis Sales Market Share by Type (2016-2026)

Figure 64. Europe Cancer Genome Analysis Sales Market Share by Application (2016-2026)

Figure 65. Europe Cancer Genome Analysis Revenue Market Share by Country (2016-2026)

Figure 66. Germany Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. France Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. United Kingdom Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Russia Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Italy Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Asia-Pacific Cancer Genome Analysis Sales Market Share by Type (2016-2026)

Figure 72. Asia-Pacific Cancer Genome Analysis Sales Market Share by Application (2016-2026)

Figure 73. Asia-Pacific Cancer Genome Analysis Revenue Market Share by Region (2016-2026)

Figure 74. China Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Japan Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Korea Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. India Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Southeast Asia Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Australia Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. South America Cancer Genome Analysis Sales Market Share by Type (2016-2026)

Figure 81. South America Cancer Genome Analysis Sales Market Share by Application (2016-2026)

Figure 82. South America Cancer Genome Analysis Revenue Market Share by Country (2016-2026)

Figure 83. Brazil Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Argentina Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Middle East and Africa Cancer Genome Analysis Sales Market Share by Type (2016-2026)

Figure 86. Middle East and Africa Cancer Genome Analysis Sales Market Share by Application (2016-2026)

Figure 87. Middle East and Africa Cancer Genome Analysis Revenue Market Share by Country (2016-2026)

Figure 88. Turkey Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Saudi Arabia Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 90. UAE Cancer Genome Analysis Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 91. Methodology

Figure 92. Research Process and Data Source